Using RT‐qPCR and Western blot analysis, we established that PSP improves T2DM conditions by modulating the mRNA and protein expression levels of IRS1, PI3K, AKT, SREBP1, and GLUT2 in the insulin signaling pathway. The gene discussed is SLC2A2; the disease is type 2 diabetes mellitus.